2,410 results on '"Montine, Thomas J"'
Search Results
152. Characteristics of oldest-old individuals with Pure Limbic-predominant age-related TDP-43 encephalopathy: a 90+ Study case series
153. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
154. Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice
155. Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased risk
156. Proteomics of resilience to Alzheimer’s disease identifies brain regional soluble Aβ levels, actin filament processes, and response to injury
157. Testing gender and longitudinal measurement invariance of the SF-36 in American Indian older adults: The strong heart study.
158. Parkinson's Progression Markers Initiative brain autopsy program
159. Cognitive resilience to three dementia-related neuropathologies in an oldest-old man: A case report from The 90+ Study
160. Semi-quantitative Assessment of Alzheimer's-like Pathology in Two Aged Polar Bears (Ursus maritimus)
161. Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease
162. Application of the condensed protocol for the NIA‐AA guidelines for the neuropathological assessment of Alzheimerʼs disease in an academic clinical practice
163. Vasodilator dysfunction and oligodendrocyte dysmaturation in aging white matter
164. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
165. List of Contributors
166. Neuroinflammation and Oxidative Injury in Developmental Neurotoxicity
167. Metrologically Traceable Quantification of 3 Apolipoprotein E Isoforms in Cerebrospinal Fluid.
168. Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease
169. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation
170. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
171. Rapid Deployment of Whole Slide Imaging for Primary Diagnosis in Surgical Pathology at Stanford Medicine
172. Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
173. Targeting LRRK2 Mutations in Parkinson's Disease
174. Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
175. Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old
176. Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
177. Discovery of 1H-Pyrazole Biaryl Sulfonamides as Novel G2019S-LRRK2 Kinase Inhibitors
178. APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease
179. Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation
180. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease
181. Formation of Novel D-Ring and E-Ring Isoprostane-Like Compounds (D4/E4-Neuroprostanes)in Vivo From Docosahexaenoic Acidt
182. Oxidative Alterations in Neurodegenerative Diseases
183. Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer’s Disease
184. A Metabolomic Aging Clock Using Human Cerebrospinal Fluid
185. Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid.
186. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
187. Cognitive resilience to three dementia-related neuropathologies in an oldest-old man: A case report from The 90+ Study.
188. Putting Humpty Dumpty Back Together Again : What Does Protein Quantification Mean in Bottom-Up Proteomics? br
189. Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's disease.
190. Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease.
191. Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity.
192. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease
193. Endogenous Brain Catechol Thioethers in Dopaminergic Neurodegeneration
194. A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer's disease.
195. LATE and potential estrogen-related risk factors collected 30 years earlier: The 90+ Study.
196. Formation of Novel Isoprostane-Like Compounds from Docosahexaenoic Acid
197. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
198. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
199. Age-Dependent Changes in the Cerebrospinal Fluid Proteome by Slow Off-Rate Modified Aptamer Array
200. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.